Automated iPSC Production via FACS Sorting and Data-Driven Batching
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing induced pluripotent stem cells (iPSCs) are time-consuming and labor-intensive, with variability in generation and culture that hinders high-throughput applications, and there is a need for automated systems to rapidly produce and isolate reproducible iPSC cell lines from diverse individuals.
Innovation Solution
The development of automated systems and methods that involve selecting and grouping cells based on characteristics like growth rates and donor attributes, using low serum or serum-free media for reprogramming, and optimizing embryoid body generation to reduce variability and enhance reprogramming efficiency, particularly through 'data-driven batching' and 'binning' techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If manual methods are used to identify and pick iPSC clones based on morphology, then cloning accuracy can be maintained, but the process becomes extremely time-consuming and labor-intensive
Solution Approach 1:
The patent replaces manual mechanical picking with automated fluorescence-activated cell sorting (FACS) technology. FACS uses fluorescent markers to automatically identify and sort iPSC clones based on their expression profiles, eliminating the need for manual morphological assessment and glass tool picking. This substitution maintains high cloning accuracy through objective fluorescent marker detection while dramatically reducing the time and labor required for the process.
Solution Approach 2:
The patent introduces fluorescent markers as intermediaries to bridge the gap between automated detection and clone identification. These markers serve as proxies for iPSC identity, allowing automated systems to accurately identify clones without requiring manual morphological evaluation. The fluorescent markers mediate the connection between cellular characteristics and automated sorting capabilities, enabling high-throughput processing while maintaining precision.
2Productivity
If automated systems are implemented to increase throughput, then productivity improves, but variability in cell generation and culture increases
Solution Approach 1:
The patent standardizes critical culture parameters including serum concentration, media composition, and incubation conditions across all automated processing steps. By controlling and optimizing these parameters, the system ensures consistent cell behavior and differentiation outcomes even at high throughput. The standardized protocols for FACS sorting, clone expansion, and differentiation maintain reliability while enabling automated high-volume production.
Solution Approach 2:
The patent implements quality control measures with feedback loops that monitor cell characteristics throughout the automated process. Fluorescent marker expression is continuously assessed to verify clone identity and purity. This feedback mechanism allows real-time detection and correction of deviations, ensuring consistent cell generation across high-throughput batches while maintaining the ability to identify and exclude anomalous samples.
3Adaptability or versatility
If traditional manual culture methods are used, then cell variability is maintained, but the process cannot support high-throughput applications
Solution Approach 1:
The patent develops universal culture protocols and reagent formulations that work consistently across diverse cell types and differentiation conditions. The standardized media compositions and culture conditions can be applied to multiple cell lines and differentiation protocols, enabling flexible adaptation to various research needs while maintaining high-throughput capability. This universality allows the automated system to handle different cell types without sacrificing productivity or requiring separate manual procedures for each cell type.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides various improved systems and methods for obtaining, generating, culturing, and handling cells, such as stem cells (including induced pluripotent stem cells or iPSCs) and differentiated cells, as well as cells and cell panels produced using such systems and methods, and uses of such cells and cell panels.